Urology Group of Southern California

Los Angeles, California 90048

3 studies enrolling now · 14 studies all time

What they study most

Benign Prostatic Hyperplasia, Bladder Cancer, Erectile Dysfunction, Hematuria - Cause Not Known, Hypogonadism, Interstitial Cystitis/Bladder Pain Syndrome, Lower Urinary Tract Symptoms, Non-muscle Invasive Bladder Cancer, Overactive Bladder, Overactive Bladder Syndrome, Prostate Adenocarcinoma, Prostate Cancer

Studies at this site

• Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine. — Recruiting now
• Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer — Recruiting now
• A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms — Recruiting now
• Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy — Recruiting now
• Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome — Completed
• INTIBIA Pivotal Study — Running, not enrolling
• A New Sildenafil Oral Film in Patients With Erectile Dysfunction — Completed
• A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer — Running, not enrolling
• Study of V117957 in Overactive Bladder Syndrome — Completed
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women — Completed
• Oral Testosterone for the Treatment of Hypogonadism — Completed